Search Results - "NOVENTA, F."

A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score by BARBAR, S., NOVENTA, F., ROSSETTO, V., FERRARI, A., BRANDOLIN, B., PERLATI, M., DE BON, E., TORMENE, D., PAGNAN, A., PRANDONI, P.

“…Background: Prophylaxis of venous thromboembolism (VTE) in hospitalized medical patients is largely underused. We sought to assess the value of a simple risk…”
Get full text

Mesoglycan for the secondary prevention of superficial vein thrombosis: a randomized, controlled, double-blind study (METRO Study)—rationale and protocol by Camporese, G., Bernardi, E., Bortoluzzi, C., Noventa, F., Simioni, P.

“…No data is available about pharmacological secondary prevention of superficial vein thrombosis (SVT) despite 10–15% of patients develop venous thromboembolic…”
Get full text

Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients by Fattovich, G, Giustina, G, Degos, F, Tremolada, F, Diodati, G, Almasio, P, Nevens, F, Solinas, A, Mura, D, Brouwer, JT, Thomas, H, Njapoum, C, Casarin, C, Bonetti, P, Fuschi, P, Basho, J, Tocco, A, Bhalla, A, Galassini, R, Noventa, F, Schalm, SW, Realdi, G

“…BACKGROUND & AIMS: Few data are available concerning the long-term prognosis of chronic liver disease associated with hepatitis C virus infection. This study…”
Get full text

Fibrosis progression in initially mild chronic hepatitis C by Boccato, S., Pistis, R., Noventa, F., Guido, M., Benvegnù, L., Alberti, A.

“…The natural history of chronic hepatitis C presenting with no/minimal liver fibrosis is uncertain with controversies on risk of progression and need for…”
Get full text

C0025: The Impact of Residual Thrombosis on the Outcome of Patients with Deep-Vein Thrombosis by Prandoni, P, Lensing, A.W.A, Prins, M.H, Noventa, F, Villalta, S

Get full text

Aspirin and recurrent venous thromboembolism by Prandoni, P, Noventa, F, Milan, M

“…While there is conclusive evidence that aspirin plays a role in reducing the risk of clinically relevant venous thromboembolism (VTE) arising in a number of…”
Get more information

Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study by MILAN, M., NOVENTA, F., GHIRARDUZZI, A., PENGO, V., VEDOVETTO, V., FILIPPI, L., CAMPELLO, E., PRANDONI, P.

Get full text

Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome by TERRIN, L, TRENTIN, L, SEMENZATO, G, DE ROSSI, A, DEGAN, M, CORRADINI, I, BERTORELLE, R, CARLI, P, MASCHIO, N, BO, M. D, NOVENTA, F, GATTEI, V

“…Activation of telomerase reverse transcriptase (hTERT) is essential for unlimited cell growth and plays a critical role in tumorigenesis. We investigated hTERT…”
Get full text

Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study by Pengo, V, Legnani, C, Noventa, F, Palareti, G

“…Oral anticoagulants (OA) are the drug of choice for stroke prevention in patients with non-rheumatic atrial fibrillation (NRAF). This clear benefit/risk ratio…”
Get more information

Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance by Bortoletto, G., Scribano, L., Realdon, S., Marcolongo, M., Mirandola, S., Franceschini, L., Bonisegna, S., Noventa, F., Plebani, M., Martines, D., Alberti, A.

“…Insulin resistance (IR) reduces response to pegylated‐interferon (PEG‐IFN)/ribavirin in chronic hepatitis C (CHC), but the mechanisms are still undefined. We…”
Get full text

Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C by Sebastiani, G., Vario, A., Ferrari, A., Pistis, R., Noventa, F., Alberti, A.

“…Hepatic iron has been described in hepatitis C virus (HCV) infection as an important cofactor of disease outcome. The mechanisms leading to hepatic iron…”
Get full text

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development by Benvegnù, L, Noventa, F, Bernardinello, E, Pontisso, P, Gatta, A, Alberti, A

“…BACKGROUND Patients with liver cirrhosis are at significant risk of hepatocellular carcinoma (HCC) that may develop as well defined nodular lesions or as more…”
Get full text

Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes by SCQUIZZATO, E, TERAMO, A, MIORIN, M, FACCO, M, PIAZZA, F, NOVENTA, F, TRENTIN, L, AGOSTINI, C, ZAMBELLO, R, SEMENZATOL, G

“…Using polymerase chain reaction (PCR)-based sequence-specific primers, the killer immunoglobulin-like receptor (KIR) genotypes of 35 patients with natural…”
Get full text

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV by Alberti, A, Morsica, G, Chemello, L, Cavalletto, D, Noventa, F, Pontisso, P, Ruol, A

“…There is controversy about clinical management of patients who persistently have antibodies to hepatitis C virus (anti-HCV) but who have no symptoms and signs…”
Get more information

Natural history and prognostic factors for chronic hepatitis type B by Fattovich, G, Brollo, L, Giustina, G, Noventa, F, Pontisso, P, Alberti, A, Realdi, G, Ruol, A

“…One hundred and five hepatitis B surface antigen (HBsAg) positive patients presenting with chronic persistent hepatitis (n = 46) or chronic active hepatitis…”
Get full text

A simple ultrasound approach for detection of recurrent proximal-vein thrombosis by PRANDONI, P, COGO, A, BERNARDI, E, VILLALTA, S, POLISTENA, P, SIMIONI, P, NOVENTA, F, BENEDETTI, L, GIROLAMI, A

“…The objective of this study was to develop a simple ultrasound method for measuring thrombus regression in patients with proximal deep-vein thrombosis (DVT)…”
Get full text

Open Repair for Ruptured Abdominal Aortic Aneurysm: Is It Possible to Predict Survival? by Antonello, M, Frigatti, P, Maturi, C, Lepidi, S, Noventa, F, Pittoni, G, Deriu, G.P, Grego, F

“…The aim of the study was to determine variables that could be used to predict survival in patients with ruptured abdominal aortic aneurysm (RAAA) and to assess…”
Get full text

Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome by Bortolotti, F, Resti, M, Marcellini, M, Giacchino, R, Verucchi, G, Nebbia, G, Zancan, L, Marazzi, M G, Barbera, C, Maccabruni, A, Zuin, G, Maggiore, G, Balli, F, Vajro, P, Lepore, L, Molesini, M, Guido, M, Bartolacci, S, Noventa, F

“…Background and aim: Little is known of hepatitis C virus (HCV) genotypes in HCV infected children. This retrospective, multicentre study investigated genotype…”
Get full text

Therapy of hepatitis C: Re‐treatment with alpha interferon by Alberti, A, Chemello, L, Noventa, F, Cavalletto, L, De Salvo, GianLuca

“…The long‐term benefit of interferon therapy in chronic hepatitis C is limited. During therapy, serum alanine aminotransferase (ALT) levels decrease to normal…”
Get full text

PREDICTION OF OESOPHAGEAL VARICES (OV) IN HEPATIC CIRRHOSIS BY SERUM NON-INVASIVE MARKERS: RESULTS OF A MULTICENTER, INTERNATIONAL STUDY by Sebastiani, G, Alberti, A, Castera, L, Fattovich, G, Halfon, P, Bourliere, M, Noventa, F, Saggioro, A, Tempesta, D

Get full text